SITC Cancer Immunotherapy CONNECT

2021 SITC Logo Crop

SITC 2021 Registration Now Open  
Participate in person or virtually at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) taking place Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Click here for more information about registering for SITC 2021.


JITC Increases Impact Factor to 13.751
The Journal for ImmunoTherapy of Cancer's (JITC) Impact Factor makes JITC the highest ranked fully open access immunology journal and places it in the top 5% percent of all journals published in the category of immunology and top 7% in the category of oncology.

Now Available: SITC Clinical Practice Guideline on Immune Checkpoint Inhibitor-related Adverse Events


Elite Program for Emerging Leaders in Cancer Immunotherapy

SITC is pleased to announce the reinvigoration of the society’s innovative program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation. Applications are due July 26 by 5 p.m. PDT.

LEARN MORE and apply


NEW: Hands-On Clinical Trial Protocol Development Workshop

Apply to attend SITC’s new Clinical Immuno-Oncology Network (SCION) Workshop, taking place Jan. 23–28, 2022, in Austin, Texas. Selected participants will develop a full cancer immunotherapy clinical trial protocol through small-group work with guidance from expert faculty during the five-day program. Applications are due Aug. 6 by 11:59 p.m. ET.

LEARN MORE and apply

2021 SITC Logo Crop

Submit your Cutting-Edge Research

The deadline to submit research for a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application is 5 p.m. PDT on July 29, 2021.


Targets for Cancer Immunotherapy: A Deep Dive

A series of eight two-hour online seminars will feature experts in a given subject area to provide an overview of the current scientific knowledge about an area of immunotherapy. An interactive Q&A session will follow the topic overview, providing attendees the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field. 



SITC's Surfaceome Workshop

Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop, Sept. 29–30, 2021, in San Diego. This SITC workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and the maximization of existing techniques. Submit your research by 5 p.m. PDT on July 22.



SITC's Bispecific T cell Engagers Workshop

Attend SITC's Bispecific T cell Engagers Workshop, Sept. 30–Oct. 1, 2021, in San Diego. This SITC workshop will focus on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, the impact of the tumor microenvironment, and advances in conditionally-active binding.



JITC Special Series: COVID-19 and Cancer Immunotherapy

Comprised of several authoritative reviews of COVID-19 and Cancer Immunotherapy, this series, edited by Paolo Antonio Ascierto, MD and Jason D. Goldman, MD, MPH, will explore basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations.


SITC's Cytokines in Cancer Immunotherapy Workshop

Attend SITC's Cytokines in Cancer Immunotherapy Workshop, Oct. 11–12, 2021, in New York. This SITC workshop will focus on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches. Submit your research by 5 p.m. EDT on July 22.

submit an abstract and REGISTER


Why I'm a SITC Member

Join Alan Hutson, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member

New Online Patient Course Available: Understanding Cancer Immunotherapy 
Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy


Immunotherapy for the Treatment of Breast and Gynecologic Cancers 

A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now

Consistent with the Safer at Home Order issued by the Department of Health Services of the State of Wisconsin, all SITC Executive Office staff will be working remotely beginning March 25, 2020, and are best reached through email. General inquiries can be sent to Thank you for understanding.


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in tumor immunology and cancer immunotherapy.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • ~In the Heights 2021 ganzer film deutsch Online Anschauen ,In the Heights Stream Deutsch , Ganzer Film In the Heights Stream Deutsch komplett, In the Heights 2021 film komplett stream Deutsch, Ganzer Film In the Heights online deutschland , In the Heights ...

  • Highly interesting workshop. Looking forward to it and hope to virtually interact with many colleagues in the field. Silvia ------------------------------ Silvia Guglietta PhD Assistant Professor Medical University of South Carolina Charleston SC - ...

  • Cancer cadrg-tacpad (Overview) Translational Advances in Cancer Prevention Agent Development Virtual Workshop on Immunomodulatory Agents Sponsored by the Division of Cancer ...

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More